Snapshot A 50-year-old woman presents to her primary care physician's office for persistently dry eyes and mouth. She reports that this started several months ago and has not improved. She has been using artificial tears for the past few weeks without much relief. She also reports feeling very tired and anxious. She has a past medical history of systemic lupus erythematosus and a family history of rheumatoid arthritis. Physical exam reveals dry mucous membranes, swollen parotid glands, and conjunctivitis on exam. She is prescribed pilocarpine and sent for an autoimmune workup. Introduction Clinical definition an autoimmune disease of the exocrine glands Epidemiology prevalence relatively common (up to 5% prevalence) demographics female > male 40-60 years of age second most common autoimmune rheumatic disease risk factors family history comorbid autoimmune disease Pathogenesis associated with HLA-DR52 environmental trigger, such as a viral infection, may cause inflammatory destruction of exocrine glands and is characterized by aggregation of lymphocytes, primarily CD4+ T-cells and memory cells the salivary and lacrimal glands are most commonly affected glandular neurodegeneration from apoptosis mediated by cytokines and inflammatory cells Associated conditions other autoimmune diseases primary biliary cholangitis CREST syndrome rheumatoid arthritis systemic lupus erythematosus marginal zone lymphoma viral infections hepatitis C virus EBV HIV Prognosis patients are at risk for non-Hodgkin lymphoma and other autoimmune diseases Presentation Symptoms sicca symptoms in > 95% of patients ↓ saliva production causing dry mouth (xerostomia) ↓ tear production causing dry eyes (keratoconjunctivitis sicca or xerophthalmia) foreign body sensation dyspareunia in women constitutional symptoms fatigue weight loss Physical exam cutaneous findings dry skin cheilitis ocular findings conjunctival injection oral findings dental caries or periodontal disease dry mucous membranes bilateral parotid gland enlargement Studies Labs positive anti-SSA (anti-Ro) (50-70% of cases) positive anti-SSB (anti-La) (50-70% of cases) positive antinuclear antibodies (50-90% of cases) possible positive rheumatoid factor (30-90% of cases) Corneal staining to assess ocular damage Labial salivary gland biopsy indication to confirm diagnosis, especially in patients with negative anti-Ro or anti-La antibodies findings dense inflammatory infiltrate in exocrine glands Making the diagnosis based on clinical presentation and laboratory studies Differential Diabetes Hepatitis C Anticholinergic drug use Mumps Treatment Medical artificial tears indication dry eyes pilocarpine or cevimeline indication dry eyes or dry mouth vitamin D supplementation indications for all patients vitamin D deficiency may increase risk of neuropathy and lymphoma Complications Dental caries Oral candidiasis Corneal abrasion or ulceration Mucosa-associated lymphoid tissue (MALT) lymphoma Parotid gland infection
QUESTIONS 1 of 2 1 2 Previous Next Lab Values Blood Hematologic Cerebrospinal Sweat, Urine, and BMI Blood, Plasma, Serum Reference Range ALT 8-20 U/L Amylase, serum 25-125 U/L AST 8-20 U/L Bilirubin, serum (adult) Total // Direct 0.1-1.0 mg/dL // 0.0-0.3 mg/dL Calcium, serum (Ca2+) 8.4-10.2 mg/dL Cholesterol, serum Rec: < 200 mg/dL Cortisol, serum 0800 h: 5-23 μg/dL //1600 h: 3-15 μg/dL 2000 h: ≤ 50% of 0800 h Creatine kinase, serum Male: 25-90 U/LFemale: 10-70 U/L Creatinine, serum 0.6-1.2 mg/dL Electrolytes, serum Sodium (Na+) 136-145 mEq/L Chloride (Cl-) 95-105 mEq/L Potassium (K+) 3.5-5.0 mEq/L Bicarbonate (HCO3-) 22-28 mEq/L Magnesium (Mg2+) 1.5-2.0 mEq/L Estriol, total, serum (in pregnancy) 24-28 wks // 32-36 wks 30-170 ng/mL // 60-280 ng/mL 28-32 wk // 36-40 wks 40-220 ng/mL // 80-350 ng/mL Ferritin, serum Male: 15-200 ng/mLFemale: 12-150 ng/mL Follicle-stimulating hormone, serum/plasma Male: 4-25 mIU/mL Female: premenopause: 4-30 mIU/mL midcycle peak: 10-90 mIU/mL postmenopause: 40-250 pH 7.35-7.45 PCO2 33-45 mmHg PO2 75-105 mmHg Glucose, serum Fasting: 70-110 mg/dL2-h postprandial:<120 mg/dL Growth hormone - arginine stimulation Fasting: <5 ng/mLProvocative stimuli: > 7ng/mL Immunoglobulins, serum IgA 76-390 mg/dL IgE 0-380 IU/mL IgG 650-1500 mg/dL IgM 40-345 mg/dL Iron 50-170 μg/dL Lactate dehydrogenase, serum 45-90 U/L Luteinizing hormone, serum/plasma Male: 6-23 mIU/mL Female: follicular phase: 5-30 mIU/mL midcycle: 75-150 mIU/mL postmenopause 30-200 mIU/mL Osmolality, serum 275-295 mOsmol/kd H2O Parathyroid hormone, serume, N-terminal 230-630 pg/mL Phosphatase (alkaline), serum (p-NPP at 30° C) 20-70 U/L Phosphorus (inorganic), serum 3.0-4.5 mg/dL Prolactin, serum (hPRL) < 20 ng/mL Proteins, serum Total (recumbent) 6.0-7.8 g/dL Albumin 3.5-5.5 g/dL Globulin 2.3-3.5 g/dL Thyroid-stimulating hormone, serum or plasma .5-5.0 μU/mL Thyroidal iodine (123I) uptake 8%-30% of administered dose/24h Thyroxine (T4), serum 5-12 μg/dL Triglycerides, serum 35-160 mg/dL Triiodothyronine (T3), serum (RIA) 115-190 ng/dL Triiodothyronine (T3) resin uptake 25%-35% Urea nitrogen, serum 7-18 mg/dL Uric acid, serum 3.0-8.2 mg/dL Hematologic Reference Range Bleeding time 2-7 minutes Erythrocyte count Male: 4.3-5.9 million/mm3Female: 3.5-5.5 million mm3 Erythrocyte sedimentation rate (Westergren) Male: 0-15 mm/hFemale: 0-20 mm/h Hematocrit Male: 41%-53%Female: 36%-46% Hemoglobin A1c ≤ 6 % Hemoglobin, blood Male: 13.5-17.5 g/dLFemale: 12.0-16.0 g/dL Hemoglobin, plasma 1-4 mg/dL Leukocyte count and differential Leukocyte count 4,500-11,000/mm3 Segmented neutrophils 54%-62% Bands 3%-5% Eosinophils 1%-3% Basophils 0%-0.75% Lymphocytes 25%-33% Monocytes 3%-7% Mean corpuscular hemoglobin 25.4-34.6 pg/cell Mean corpuscular hemoglobin concentration 31%-36% Hb/cell Mean corpuscular volume 80-100 μm3 Partial thromboplastin time (activated) 25-40 seconds Platelet count 150,000-400,000/mm3 Prothrombin time 11-15 seconds Reticulocyte count 0.5%-1.5% of red cells Thrombin time < 2 seconds deviation from control Volume Plasma Male: 25-43 mL/kgFemale: 28-45 mL/kg Red cell Male: 20-36 mL/kgFemale: 19-31 mL/kg Cerebrospinal Fluid Reference Range Cell count 0-5/mm3 Chloride 118-132 mEq/L Gamma globulin 3%-12% total proteins Glucose 40-70 mg/dL Pressure 70-180 mm H2O Proteins, total < 40 mg/dL Sweat Reference Range Chloride 0-35 mmol/L Urine Calcium 100-300 mg/24 h Chloride Varies with intake Creatinine clearance Male: 97-137 mL/minFemale: 88-128 mL/min Estriol, total (in pregnancy) 30 wks 6-18 mg/24 h 35 wks 9-28 mg/24 h 40 wks 13-42 mg/24 h 17-Hydroxycorticosteroids Male: 3.0-10.0 mg/24 hFemale: 2.0-8.0 mg/24 h 17-Ketosteroids, total Male: 8-20 mg/24 hFemale: 6-15 mg/24 h Osmolality 50-1400 mOsmol/kg H2O Oxalate 8-40 μg/mL Potassium Varies with diet Proteins, total < 150 mg/24 h Sodium Varies with diet Uric acid Varies with diet Body Mass Index (BMI) Adult: 19-25 kg/m2 Calculator ( ) xy AC 7 8 9 ÷ 4 5 6 × 1 2 3 - 0 . = + Sorry, this question is for PEAK Premium Subscribers only Upgrade to PEAK (M1.MK.202) A 48-year-old female presents to your office with a 1-year history of dry eyes and difficulty swallowing. She complains of blinking frequently and of eye strain while using her computer at work. She also reports stiffness in her knees and lower back. Past medical history is unremarkable and she does not take medications. She denies cigarette or alcohol use. Family history is notable for Hashimoto's thyroiditis in her mother. Physical exam shows dry oral mucosa and enlargement of the parotid glands. Which of the following serologies is likely to be positive in this patient? Review Topic QID: 106236 1 Anti-SS-A 73% (86/118) 2 Anti-CCP 3% (4/118) 3 Anti-dsDNA 4% (5/118) 4 Anti-Smith 6% (7/118) 5 Anti-Jo-1 12% (14/118) M1 Select Answer to see Preferred Response PREFERRED RESPONSE 1